Возраст домена | n/a |
Дата окончания | n/a |
PR | 4 |
ИКС | n/a |
Страниц в Google | 79 |
Страниц в Яндексе | 51 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 10400325 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Ensemble Therapeutics - Controlling Chemistry with the Powers of DNA
n/a
n/a
ISO-8859-1
20.93 КБ
695
5 999 симв.
5 108 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() |
21 | 4 |
0 | 3547816 | ![]() | |
![]() ![]() |
3 | 9 |
0 | 5 | ![]() | |
![]() ![]() |
3 | 9 |
0 | 25 | ![]() | |
![]() ![]() |
2 | 5 |
10 | 5376589 | ![]() |
|
![]() |
2 | 7 |
0 | 408 | ![]() | |
![]() ![]() |
2 | 6 |
0 | 87045 | ![]() | |
![]() |
2 | n/a | 0 | Нет данных | ![]() |
|
![]() |
2 | 4 |
0 | 21025191 | ![]() |
|
![]() |
2 | 6 |
0 | 1584 | ![]() | |
![]() ![]() |
2 | 7 |
0 | 2914 | ![]() | |
Еще 18 сайтов после авторизации |
Данные предоставлены сервисом semrush
Данные linkpad ( 20 Ноября 2016 ) | |
Количество ссылок на сайт | 20 |
Количество доменов, которые ссылаются на сайт | 10 |
Количество найденных анкоров | 8 |
Исходящие (внешние) ссылки домена | 31 |
Количество доменов, на которые ссылается сайт | 22 |
Количество исходящих анкоров | 14 |
Внешние ссылки главной страницы ( 5 ) | |
dddmag.com/articles/2013/05/producing-orally-bioavailable-bi... | Drug Discovery & Development: "Producing Orally Bioavailable Biologics" |
eorder.sheridan.com/3_0/display/index.php?flashprint=1708 | Nature Reviews Drug Discovery: "Protein-protein interaction inhibitors get into the groove |
xconomy.com/boston/2011/07/19/ensemble-therapeutics-moves-ah... | Xconomy: "Ensemble Therapeutics Moves Ahead With Mid-Sized Drugs in a Super-Sized Library" |
cenblog.org/the-haystack/2011/04/ensemble-hits-macrocycle-mi... | C&EN The Haystack Blog: "Ensemble hits Macrocycle Milestone" |
digizyme.com | design by Digizyme |
Внутренние ссылки главной страницы ( 39 ) | |
about/index.html | <img> |
sciTech/index.html | <img> |
pipeline/index.html | <img> |
news/index.html | <img> |
careers/index.html | <img> |
contact/index.html | Contact Us |
news/pdfs/Ensemble Fact Sheet_122213.pdf | t |
news/pdfs/PR08062013.pdf | Ensemble Therapeutics Forms Global Strategic Collaboration for Development of Oral, Macrocyclic IL-17 Antagonists and Addition... |
news/pdfs/PR7172013.pdf | Ensemble Therapeutics and Alexion Initiate Collaboration to Discover Macrocycle Drug Candidates Targeting Patients with Severe... |
news/pdfs/Ensemble ACS 4.1.13.pdf | Ensemble Therapeutics to Present Data on IL-17A Inhibitors that are Novel, Oral Macrocycles Against Previously Undruggable Targ... |
news/pdfs/Ensemble TriConf.2.13.2013.pdf | Ensemble Therapeutics Presents Data Demonstrating Unique Properties of Synthetic Macrocycles for Pursuing Challenging Targets |
news/pdfs/PR1192012 ACR Oral Efficacy.pdf | Ensemble Therapeutics Presents Oral Efficacy of First-in-Class Small Molecule Targeting IL-17 for Inflammation in Preclinical ... |
news/pdfs/ACR Poster DJL-v1-1 (2).pdf | Download IL-17 ACR Poster |
news/pdfs/BIPR1112012.pdf | Ensemble Therapeutics and Boehringer Ingelheim Initiate Collaboration to Discover Macrocycle Drug Candidates |
news/pdfs/PR20121029.pdf | Ensemble Therapeutics to Present at 2012 ACR Annual Meeting |
news/pdfs/pr05292012.pdf | Ensemble Therapeutics and Genentech Initiate Collaboration to Discover Macrocyclic Drug Candidates |
news/pdfs/Ensemble.IL17 press release.FINAL[1].pdf | Ensemble Therapeutics Advances Macrocycle IL-17 Antagonist Program: Reports First Known Small Molecule Inhibitors of Important A... |
news/pdfs/Ensemble BMS extension press release 01-05-11.FINA... | Ensemble Therapeutics Extends Macrocycle Drug Discovery Alliance with Bristol-Myers Squibb |
news/pdfs/pr20110706.pdf | Ensemble Therapeutics Receives Two Notices of Allowance for Fundamental Patents to DNA-Programmed Chemistry for Novel Macrocycle... |
news/pdfs/pr20110412.pdf | Ensemble Achieves Milestone in Bristol-Myers Squibb Collaboration |
news/pdfs/pr20101105.pdf | Ensemble Awarded Three Therapeutic Discovery Project Grants Totaling $744,000 |
news/pdfs/pr20100915.pdf | Ensemble Therapeutics Appoints Ted Hibben as Senior Vice President, Corporate Development |
news/pdfs/pr20100824.pdf | Ensemble Therapeutics Presents Data at American Chemical Society National Meeting |
news/pdfs/pr20100622.pdf | Ensemble Evolves Name to Ensemble Therapeutics Corporation and Also Announces New Strategic Investor: Kisco Ltd. |
news/pdfs/pr20100106.pdf | Ensemble Discovery Initiates Collaboration with Pfizer to Develop Novel Drugs Against Protein-Protein Interaction Targets |
news/pdfs/pr20090415.pdf | Ensemble Discovery Initiates Collaboration with Bristol-Myers Squibb to Develop Drugs in Novel Therapeutic Class |
news/pdfs/Xconomy Ensemble 8_6_13.pdf | Xconomy: Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs |
news/pdfs/BWT 110212 Macrocycle pdf.pdf | BioWorld Today: "Macrocycle Diary's New Entry: Ensemble Deal with Boehringer" |
news/pdfs/091712_ExcitedAboutCycling.pdf | BioCentury: "Excited About Cycling" |
news/pdfs/061112_Tools_Ensemble.pdf | BioCentury: "Assembling Around Ensemblins" |
news/pdfs/Scrip 3602_Genentech_p13.pdf | SCRIP: "Genentech, Ensemble partner for macrocycle drug discovery" |
news/pdfs/012612_Cover.pdf | SciBX cover story: "Macrocycles by the Trillions” |
news/pdfs/pr20111201.pdf | BioWorld Today: "Macrocycles: Going where no drugs have gone before" |
news/pdfs/pr20110412_pinksheet.pdf | The Pink Sheet: "Delivery Of First Macrocyle To Bristol-Myers Squibb Enables Ensemble Therapeutics To Look Ahead |
news/pdfs/EnsembleTherapeutics1103su.pdf | START-UP: "Making mid-sized macrocyclic molecules, en masse" |
news/pdfs/0746_001.pdf | Chemistry World Jobs "Company Profile: Chemical Ensemble |
news/pdfs/pr201103.pdf | - |
footer/sitemap.html | Sitemap |
footer/legal.html | Legal |
Domain Name: ENSEMBLETX.COM
Registrar URL: http://www.godaddy.com
Registrant Name: Nathan Walsh
Registrant Organization: Ensemble Discovery
Name Server: NS17.DOMAINCONTROL.COM
Name Server: NS18.DOMAINCONTROL.COM
For complete domain details go to:
http://who.godaddy.com/whoischeck.aspx?domain=ENSEMBLETX.COM
США - Шарлотт - 65.213.146.70
American City Business Journals
Verizon Business
HTTP/1.1 200 OK
Connection: Keep-Alive
Content-Type: text/html
Last-Modified: Sat, 28 Apr 2018 00:23:40 GMT
Accept-Ranges: bytes
Content-Length: 21436
Date: Sun, 02 Feb 2020 15:00:22 GMT
Server: LiteSpeed
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"